NCT03597269View on ClinicalTrials.gov

Evaluation of Pneumococcal Vaccine Coverage

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 15, 2017

Primary Completion Date

January 31, 2018

Study Completion Date

December 31, 2018

Conditions
Immunocompromised Patients and Non-immunosuppressed Patients at Risk With an Indication for Pneumococcal Vaccination
Trial Locations (1)

75014

Groupe Hospitalier Paris Saint-Joseph, Paris

All Listed Sponsors
lead

Fondation Hôpital Saint-Joseph

OTHER

NCT03597269 - Evaluation of Pneumococcal Vaccine Coverage | Biotech Hunter | Biotech Hunter